Your browser doesn't support javascript.
loading
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
Lam, Thomas B L; MacLennan, Steven; Willemse, Peter-Paul M; Mason, Malcolm D; Plass, Karin; Shepherd, Robert; Baanders, Ruud; Bangma, Chris H; Bjartell, Anders; Bossi, Alberto; Briers, Erik; Briganti, Alberto; Buddingh, Karel T; Catto, James W F; Colecchia, Maurizio; Cox, Brett W; Cumberbatch, Marcus G; Davies, Jeff; Davis, Niall F; De Santis, Maria; Dell'Oglio, Paolo; Deschamps, André; Donaldson, James F; Egawa, Shin; Fankhauser, Christian D; Fanti, Stefano; Fossati, Nicola; Gandaglia, Giorgio; Gillessen, Silke; Grivas, Nikolaos; Gross, Tobias; Grummet, Jeremy P; Henry, Ann M; Ingels, Alexandre; Irani, Jacques; Lardas, Michael; Liew, Matthew; Lin, Daniel W; Moris, Lisa; Omar, Muhammad Imran; Pang, Karl H; Paterson, Catherine C; Renard-Penna, Raphaële; Ribal, Maria J; Roobol, Monique J; Rouprêt, Morgan; Rouvière, Olivier; Sancho Pardo, Gemma; Richenberg, Jonathan; Schoots, Ivo G.
Afiliación
  • Lam TBL; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK. Electronic address: thomas.lam@nhs.net.
  • MacLennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
  • Willemse PM; Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Mason MD; Division of Cancer and Genetics, School of Medicine Cardiff University, Velindre Cancer Centre, Cardiff, UK.
  • Plass K; EAU Guidelines Office, Arnhem, The Netherlands.
  • Shepherd R; EAU Guidelines Office, Arnhem, The Netherlands.
  • Baanders R; Oxford, UK.
  • Bangma CH; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Bjartell A; Department of Urology, Skåne University Hospital Malmö, Lund University, Lund, Sweden.
  • Bossi A; Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France.
  • Briers E; Hasselt, Belgium.
  • Briganti A; Department of Urology, Scientific Institute and University Vita-Salute San Raffaele Hospital, Milan, Italy.
  • Buddingh KT; HagaZiekenhuis, The Hague, The Netherlands.
  • Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Colecchia M; Uropathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Cox BW; Department of Radiation Medicine, Zucker School of Medicine, Hempstead, New York, NY, USA.
  • Cumberbatch MG; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Davies J; Wales, UK.
  • Davis NF; Department of Urology, Beaumont and Connolly Hospitals, Dublin, Ireland; Royal College of Surgeons in Ireland, Dublin, Ireland.
  • De Santis M; Department of Urology, Charité University Hospital, Berlin, Germany.
  • Dell'Oglio P; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; ORSI Academy, Melle, Belgium.
  • Deschamps A; Europa Uomo, Antwerp, Belgium.
  • Donaldson JF; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Egawa S; Asian School of Urology, UAA, Jikei University School of Medicine, Tokyo, Japan.
  • Fankhauser CD; Department of Urology, University of Zurich, Zurich, Switzerland.
  • Fanti S; Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Italy.
  • Fossati N; Department of Urology, Scientific Institute and University Vita-Salute San Raffaele Hospital, Milan, Italy.
  • Gandaglia G; Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Gillessen S; Division of Cancer Sciences, University of Manchester and The Christie, Manchester, UK; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, University of Bern, Bern, Switzerland.
  • Grivas N; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Gross T; Department of Urology, University of Bern, Bern, Switzerland.
  • Grummet JP; Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.
  • Henry AM; Leeds Cancer Centre, St. James's University Hospital, Leeds, UK.
  • Ingels A; Department of Urology, Henri Mondor Hospital, Créteil, France.
  • Irani J; University Hospital of Bicêtre-Paris Sud-Saclay University, Le Kremlin Bicêtre, France.
  • Lardas M; Department of Reconstructive Urology and Surgical Andrology, Metropolitan General, Athens, Greece.
  • Liew M; Department of Urology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
  • Lin DW; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Urology, University of Washington, Seattle, WA, USA.
  • Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.
  • Omar MI; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
  • Pang KH; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Paterson CC; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; University of Canberra, School of Nursing, Midwifery and Public Health, Canberra, Australia; Robert Gordon University, School of Nursing and Midwifery, Aberdeen, UK.
  • Renard-Penna R; Academic Department of Radiology, Sorbonne Université, GRC no 5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière-Hôpital Tenon, Paris, France.
  • Ribal MJ; Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Roobol MJ; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Rouprêt M; Urology Department, Sorbonne Université, GRC no 5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Rouvière O; Hospices Civils de Lyon, Department of Urinary and Vascular Imaging, Hôpital Edouard Herriot, Lyon, France; Université de Lyon, Université Lyon 1, Faculté de Médecine Lyon Est, Lyon, France.
  • Sancho Pardo G; Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Richenberg J; Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School, Brighton, Sussex, UK.
  • Schoots IG; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eur Urol ; 76(6): 790-813, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31587989
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Guideline / Qualitative_research / Systematic_reviews Límite: Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Guideline / Qualitative_research / Systematic_reviews Límite: Humans / Male Idioma: En Año: 2019 Tipo del documento: Article